Home › Investor Centre › Investor news › Regulatory Announcements 2008
14 November 08 Change of Adviser
31 October 08 Director or PDMR Shareholding and Total Voting Rights
17 October 08 Additional listing
15 October 08 Cambridge biostability agreement
08 October 08 Change of Broker and Nominated Adviser Name
06 October 08 Lipoxen announces Board Changes
02 October 08 Lipoxen Chief Scientific Officer, Professor Gregory Gregoriadis, Awarded Two Lifetime Achievement Honours
02 October 08 Total Voting Rights
22 September 08 Lipoxen to present at the SMi Drug Delivery Global Summit
05 September 08 Holdings in Company
20 August 08 Additional Listing
18 August 08 Lipoxen Strengthens Management Team
01 August 08 Interim report and unaudited accounts for the six months ended 30th June 2008
26 June 08 Annual report for the year ended 31st December 2007
29 May 08 Phase I Results
21 April 08 Phase I Results
17 March 08 Patent Grant
14 March 08 Technology Transfer
25 February 08 Sachs Associates Conference
13 February 08 Phase I EPO study initiated
11 February 08 Change of Advisor
28 January 08 SuliXen enters phase I trial
Back to Investor news